Search results for "BOC"

showing 10 items of 477 documents

Flemón parafaríngeo por cuerpo extraño metálico

1998

Los flemones y abcesos parafaríngeos, comunes en la era preantibiótica, son actualmente una entidad poco frecuente. Es necesario un diagnóstico y actitud terapéutica precoz para impedir acrecentar la morbimortalidad asociada. La mayoría de casos descritos se deben a perforaciones de faringe y esófago o por complicación de infecciones del tracto aerodigestivo superior. en un 15% de los casos nos encontraremos con una fase previa al abceso, denominada celulitis, sin que se haya formado colección purulenta, que puede ser solucionado con tratamiento antibiótico sin precisar drenaje quirúrgico. La paciente que presentamos empezó a referir sintomatología después de veinte años de permanencia de u…

Boca Malalties
researchProduct

Clinical and radiological course in apicoectomies with the Erbium : YAG LASER

2007

A study is made of the efficacy of the Erbium: YAG laser in granulomatous periapical lesions, based on clinical and radiographic controls. The study comprised a series of 45 patients amenable to periapical surgical treatment of incisors, canines and premolars. A conventional surgical technique was used, with silver amalgam retrograde filling and irradiation of the bone defect and remnant root cement with the Erbium: YAG laser. Clinical and radiographic controls were made during 24 months, assessing the absence of symptoms and the presence of pain, swelling or fistula and ossification of the lesions, respectively. The clinical course proved asymptomatic in 95.5% of the cases. As regards remo…

Boca-CirugíaUNESCO::CIENCIAS MÉDICASOdontologíaYAG laser [Erbium]periapical surgery:CIENCIAS MÉDICAS [UNESCO]retrograde fillingDientes-Enfermedadessilver amalgam
researchProduct

ISomerization of xylene: MINDO/3 study of the cyclization of benzenium cation into bicyclo[3.1.0]hexenyl cation

1989

Abstract A MINDO/3 study of thermal electrocyclic closing of the benzenium cation to form a bicyclo[3.1.0]hexenyl cation is presented. The calculated mechanism discusses the possibility of cyclization of xylenium cations on a silica catalyst or in superacid media. The structure and energy of the transition state, the enthalpies of isomerization and barriers of activation were calculated for the following processes: isomerization of 2,6-dimethylbenzenium cation into 2,6-dimethylbicyclo[3.1.0]hexenyl cation, isomerization of 2,4-dimethylbenzenium cation into 2,4-dimethylbicyclo[3.1.0]-hexenyl cation, and isomerization of benzenium cation into bicyclo[3.1.0]-hexenyl cation. Equilibrium and kin…

chemistry.chemical_compoundReaction rate constantBicyclic moleculeReaction stepChemistryGeneral EngineeringCationic polymerizationSuperacidCarbocationPhotochemistryMedicinal chemistryMINDOIsomerizationJournal of Molecular Catalysis
researchProduct

I laureati triennali

2010

sbocchi occupazionali post-laureaSettore SECS-S/05 - Statistica Sociale
researchProduct

Oral cancer risk and molecular markers

2004

El aspecto clínico y en especial el grado de displasia que pueden presentar las lesiones precancerosas de la cavidad oral sugieren su capacidad potencial de malignización. Cada vez es más frecuente encontrar investigaciones orientadas hacia la búsqueda de nuevos marcadores, más específicos, que contribuyan a determinar el grado de alteración celular y permitan una mayor aproximación al conocimiento del grado de degeneración maligna de aquellas lesiones. En el presente trabajo de revisión se repasan los conceptos más actuales de estos marcadores, agrupados por familias: marcadores de crecimiento tumoral; marcadores de supresión tumoral y de respuesta antitumoral; marcadores de angiogénesis; …

Mouthleucoplasia oralBocaMarcadors tumoralsOdontologíaOral medicine:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saluddisplasia epitelialcarcinoma escamoso oralTumor markersUNESCO::CIENCIAS MÉDICASEstomatologiamarcadores tisularesCàncerMarcadores molecularesTumorsCancer
researchProduct

ChemInform Abstract: Synthesis of Sesquiterpenes via Silicon-Guided Rearrangement of Epoxydecalins

2009

A survey of the rearrangement of methyldecalins via C-5 carbocation intermediates, with special attention to the silicon-guided rearrangement of epoxydecalins is provided. A TMS group properly posi...

TerpeneSiliconChemistryStereochemistryGroup (periodic table)chemistry.chemical_elementGeneral MedicineCarbocationChemInform
researchProduct

Silicon guided rearrangement of epoxydecalines to spirocyclic compounds. Synthesis of gleenol and axenol from carvone

2005

Abstract The synthesis of the spirocyclic sesquiterpenes (−)-gleenol and (−)-axenol in enantiomerically pure form has been achieved starting from R-(−)-carvone. The key step is the silicon guided acid-promoted rearrangement of a 9-trimethylsilyl-5,6-epoxy-noreudesmane prepared from 3-trimethylsilyldihydrocarvone in several steps involving Robinson annulation, enone deconjugation and epoxidation. Acid treatment of the epoxy-noreudesmane gave a norspiroaxane as the main product, which was used as intermediate for the synthesis of two naturally occurring sesquiterpenes gleenol and axenol.

CarvoneSiliconStereochemistryOrganic Chemistrychemistry.chemical_elementCarbocationBiochemistrychemistry.chemical_compoundchemistryDrug DiscoveryRobinson annulationOrganic chemistryAcid treatmentEnoneTetrahedron
researchProduct

Thrombotic thrombocytopenic purpura (TTP) leading to pseudotumour's autoimmune pancreatitis (AIP): A case report

2012

International audience; Introduction: Autoimmune pancreatitis is an idiopathic inflammatory disease that produces pancreatic masses and ductal strictures. This benign disease can be associated with extrapancreatic manifestations including cholangitis, sialadenitis, inflammatory bowel disease or retroperitoneal fibrosis, mediastinal adenopathy, interstitial nephritis mainly due to immunoglobulin G4 (Ig G4), and occasional association with other auto-immune diseases. Observation: We report a 57-year-old woman who developed thrombotic thrombocytopenic purpura (UP) and pseudo-tumour's seronegative autoimmune pancreatitis (ATP) type 1. The patient was initially treated with pulse corticosteroids…

medicine.medical_specialtyVON-WILLEBRAND-FACTOREndocrinology Diabetes and Metabolismmedicine.medical_treatmentInterstitial nephritisAnti-Inflammatory AgentsThrombotic thrombocytopenic purpuraRetroperitoneal fibrosisGastroenterologyInflammatory bowel diseaseDISEASEAutoimmune DiseasesAntibodies Monoclonal Murine-Derived03 medical and health sciences0302 clinical medicineThrombotic thrombocytopenic purpuraInternal medicine[SDV.IDA]Life Sciences [q-bio]/Food engineeringmedicineHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringSYSTEMIC-LUPUS-ERYTHEMATOSUSAutoimmune pancreatitisAutoimmune pancreatitisPurpura Thrombotic ThrombocytopenicHepatologybusiness.industryENTITYGastroenterologyMiddle Agedmedicine.diseaseSialadenitis3. Good healthPancreatitis030220 oncology & carcinogenesisImmunologyFemale030211 gastroenterology & hepatologyRituximabPlasmapheresismedicine.symptombusinessRituximabmedicine.drug
researchProduct

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

2013

International audience; Boceprevir (BOC) added to peginterferon alfa-2b (PegIFN) and ribavirin (RBV) significantly increases sustained virologic response (SVR) rates over PegIFN/RBV alone in previously untreated adults with chronic hepatitis C genotype 1. We evaluate the relationship of incident anemia with triple therapy. A total of 1,097 patients received a 4-week lead-in of PegIFN/RBV followed by: (1) placebo plus PegIFN/RBV for 44 weeks (PR48); (2) BOC plus PegIFN/RBV using response-guided therapy (BOC/RGT); and (3) BOC plus PegIFN/RBV for 44 weeks (BOC/PR48). The management of anemia (hemoglobin [Hb]<10 g/dL) included RBV dose reduction and/or erythropoietin (EPO) use. A total of 1,080…

Male[SDV]Life Sciences [q-bio]MedizinGastroenterologyPolyethylene GlycolsPlaceboschemistry.chemical_compoundHemoglobins0302 clinical medicinehemic and lymphatic diseasesMedicine030212 general & internal medicineChronicSettore MED/12 - GastroenterologiaInterferon-alpha; Serine Proteinase Inhibitors; Proline; Recombinant Proteins; Hematinics; Humans; Ribavirin; Anemia; Antiviral Agents; Drug Therapy Combination; Erythropoietin; Hemoglobins; Adult; Treatment Outcome; Placebos; Polyethylene Glycols; Hepatitis C Chronic; Female; MaleAnemiaHepatitis CHepatitis CRecombinant Proteins3. Good health[SDV] Life Sciences [q-bio]Treatment OutcomeCombinationPeginterferon alfa-2b030211 gastroenterology & hepatologyDrug Therapy CombinationFemalemedicine.drugAdultmedicine.medical_specialtySerine Proteinase InhibitorsProlineAnemiaInterferon alpha-2PlaceboAntiviral Agentsprotease inhibitor03 medical and health sciencesDrug TherapyInternal medicineBoceprevirRibavirinHumansAdverse effectErythropoietinHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C Chronicmedicine.diseaseSurgerychemistryErythropoietinHematinicsbusiness
researchProduct

Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.

2004

Background and Objectives. Essential thrombocythemia (ET) is a Philadelphia chromosome-negative chronic myeloproliferative disorder (CMPD) whose diagnosis, according to the Polycythemia Vera Study Group (PVSG) criteria, does not include histopathological data. The new WHO classification of CMPD has supplied new diagnostic guidelines which highlight the value of histopathology and facilitate a more precise differentiation of ET from reactive conditions and other CMPD. Design and Methods. Bone marrow biopsies from 142 adult patients diagnosed with ET according to PVSG criteria were evaluated using the new WHO classification. Megakaryocyte morphology and arrangement, amount of fibrosis and a c…

AdultAged 80 and overAge DistributionAntigens CDBone MarrowBiopsyHumansReproducibility of ResultsAntigens CD34Mast Cell microenvironment angioimmunoblasticMiddle AgedAgedThrombocythemia Essential
researchProduct